18 THUMBS UP: FDA advisers vote 18-4 to recommend the agency approve sales of lorcaserin, which could be the country's first new prescription diet drug in over a decade.
STOCK SURGE: Shares nearly doubled in after-hours trading, as lorcaserin could become the small company's first approved product.
NEXT STEPS: Maker Arena Pharmaceuticals says it will work with the FDA as it finishes its review, with a June 27 target for a final decision. The agency had rejected lorcaserin in 2010 over possible heart risks, but Arena tried again with additional data.
UK Conservative: The Magna Carta is the 'Most Important Bargain Struck' in Human History | Daniel Doherty
Unreal: Gun Used in Terror Attack on Mohammed Cartoon Contest Sold Through Operation Fast and Furious | Katie Pavlich
WH Totally Supports What Planned Parenthood Is Doing, Notes Its 'High Ethical Standard' | Leah Barkoukis